How This Evidence Evolved
Burn Resuscitation Fluids
Addressing fluid creep and optimizing burn shock resuscitation
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Follow-up studies, subgroup analyses, and real-world validation
24-hour total fluid: vitamin C 3.0 vs control 5.5 mL/kg/% burn (P<.01)
Death or persistent organ dysfunction at day 28: vitamin C 40.8% vs placebo 29.7% (adjusted RR 1.28, 95% CI 0.99–1.65; P=.06); mortality 15.0% vs 7.6%
Integration into clinical practice guidelines and recommendations
Start at 2 mL/kg/% TBSA. Consider albumin, especially for larger burns, to reduce fluid volumes and improve urine output. Selectively monitor intra-abdominal and intraocular pressure.
Current standard of care and ongoing research directions
Landmark Trials in This Story
Is supra-Baxter resuscitation in burn patients a new phenomenon?
Fluid volumes in matched historical cohorts
The phenomenon of "fluid creep" in acute burn resuscitation
Resuscitation volumes vs Parkland predictions
Burn Resuscitation Practices in North America: Results of the Acute Burn ResUscitation Multicenter Prospective Trial (ABRUPT).
Albumin and crystalloid resuscitation practices
Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study.
24-hour total fluid: vitamin C 3.0 vs control 5.5 mL/kg/% burn (P<.01)
High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury: The VICTORY Randomized Clinical Trial.
Death or persistent organ dysfunction at day 28: vitamin C 40.8% vs placebo 29.7% (adjusted RR 1.28, 95% CI 0.99–1.65; P=.06); mortality 15.0% vs 7.6%
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.